Entity
Description
  • Value proposition

    The future of neuroimaging is here.
    Qynapse offers groundbreaking peace of mind by providing results you can trust.

    The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust.

    Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and reliable predictors and objective measures of devastating CNS disorders such as Alzheimer's disease, multiple sclerosis and Parkinson’s disease.

    We are constantly evolving, refining and testing our FDA-cleared and CE-marked neuroimaging software platform, QyScore®, which is powered by proprietary Artificial Intelligence, to provide physicians, pharma researchers and payers a reliable layer of precision when reading an MRI scan. QyPredict®, our predictive research-use-only platform powered by machine learning algorithms, is being designed to transform what we know about CNS disease trajectory, with the potential to dramatically increase the likelihood of a successful clinical trial.

    Together, we are moving forward to a brighter and more accurate future of diagnosis and treatment for central nervous system diseases.

    Medical device, Neurology, Neuroimaging, Artificial Intelligence, Diagnosis, Prediction, Disease Trajectory, Monitoring, Drug Efficacy, Drug Safety, Personalized Medicine, Clinical Trials, Clinical Research, Central Nervous System, Azheimer's, Parkinson's, Dementia, Multiple Sclerosis, Stroke, and Psychiatry

  • Original language

    The future of neuroimaging is here.
    Qynapse offers groundbreaking peace of mind by providing results you can trust.

    The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust.

    Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and reliable predictors and objective measures of devastating CNS disorders such as Alzheimer's disease, multiple sclerosis and Parkinson’s disease.

    We are constantly evolving, refining and testing our FDA-cleared and CE-marked neuroimaging software platform, QyScore®, which is powered by proprietary Artificial Intelligence, to provide physicians, pharma researchers and payers a reliable layer of precision when reading an MRI scan. QyPredict®, our predictive research-use-only platform powered by machine learning algorithms, is being designed to transform what we know about CNS disease trajectory, with the potential to dramatically increase the likelihood of a successful clinical trial.

    Together, we are moving forward to a brighter and more accurate future of diagnosis and treatment for central nervous system diseases.

  • Home - Qynapse - The future of neuroimaging is here

    The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust.

  • https://qynapse.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Eisai Co., Ltd.
Eisai Co., Ltd.
Pharmaceutical
Eisai Co., Ltd.
Pharmaceutical
Other

3 Jul 2024


Dedalus Dedalus
Other

7 Mar 2023


PariSanté Campus PariSanté Campus
Other

13 Sep 2022


Digital Pharma Lab
Digital Pharma Lab
Pharmaceutical, Health, Business Consulting and Services
Digital Pharma Lab
Pharmaceutical, Health, Business Consulting and Services
Other

29 Jun 2023


Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP) Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP)
Health, Medical Practices
Other

24 Mar 2023


Amazon Web Services (AWS)
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Other

27 Jan 2023


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

29 Nov 2022


Institut du Cerveau – Paris Brain Institute
Institut du Cerveau – Paris Brain Institute
Startup accelerator & VC, Biotechnology Research
Institut du Cerveau – Paris Brain Institute
Startup accelerator & VC, Biotechnology Research
Other

24 Mar 2023


STATION F
STATION F
Startup accelerator & VC, Software Development
STATION F
Startup accelerator & VC, Software Development
Other

16 Nov 2022


Agoranov
Agoranov
Startup accelerator & VC, Technology, Information and Internet
Agoranov
Startup accelerator & VC, Technology, Information and Internet
Not capitalistic
Partnership
Event

12 Apr 2018


Similar entities
Loading...
Loading...
Social network dynamics